Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

134 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Comparison of two initial mobilizing strategies of peripheral blood stem cells for autologous transplantation in patients with lymphoma and human immunodeficiency virus infection].
Sagüés M, Sancho JM, Serrano D, Balsalobre P, Gayoso J, Morgades M, Conde E, Iriondo A, Varela R, Escoda L, Xicoy B, Espigado I, Fernández-Abellán P, Díez JL, Ribera JM. Sagüés M, et al. Among authors: diez jl. Med Clin (Barc). 2012 Jul 21;139(5):192-6. doi: 10.1016/j.medcli.2011.05.013. Epub 2011 Jul 31. Med Clin (Barc). 2012. PMID: 21807388 Spanish.
Nonmyeloablative stem cell transplantation is an effective therapy for refractory or relapsed hodgkin lymphoma: results of a spanish prospective cooperative protocol.
Alvarez I, Sureda A, Caballero MD, Urbano-Ispizua A, Ribera JM, Canales M, García-Conde J, Sanz G, Arranz R, Bernal MT, de la Serna J, Díez JL, Moraleda JM, Rubió-Félix D, Xicoy B, Martínez C, Mateos MV, Sierra J. Alvarez I, et al. Among authors: diez jl. Biol Blood Marrow Transplant. 2006 Feb;12(2):172-83. doi: 10.1016/j.bbmt.2005.09.009. Biol Blood Marrow Transplant. 2006. PMID: 16443515 Free article. Clinical Trial.
[No title available]
[No authors listed] [No authors listed] PMID: 36164212
Risk factors for acute graft-versus-host disease in patients undergoing transplantation with CD34+ selected blood cells from HLA-identical siblings.
Urbano-Ispizua A, Rozman C, Pimentel P, Solano C, de la Rubia J, Brunet S, Pérez-Oteyza J, Ferrá C, Zuazu J, Caballero D, Bargay J, Carvalhais A, Díez JL, Espigado I, Alegre A, Rovira M, Campilho F, Odriozola J, Sanz MA, Sierra J, García-Conde J, Montserrat E; Spanish Group for Allogeneic Peripheral Blood Transplantation (Grupo Español de Trasplante Hemopoyético) and Instituto Português de Oncologia-Porto. Urbano-Ispizua A, et al. Among authors: diez jl. Blood. 2002 Jul 15;100(2):724-7. doi: 10.1182/blood-2001-11-0057. Blood. 2002. PMID: 12091376 Free article.
Phase I/II trials of autologous peripheral blood stem cell transplantation in autoimmune diseases resistant to conventional therapy: preliminary results from the Spanish experience.
Espigado I, Marín-Niebla A, Rovira M, Juliá A, Rodríguez JM, Altés A, Arranz R, Bargay J, Diez JL, Forés R, Morales A, Graus F, Messague I, Hernández JC, Parody R, Richard C, Ferrá C, García A, Carreras E. Espigado I, et al. Among authors: diez jl. Transplant Proc. 2003 Mar;35(2):742-3. doi: 10.1016/s0041-1345(03)00071-x. Transplant Proc. 2003. PMID: 12644118 Clinical Trial. No abstract available.
Favourable effect of the combination of acute and chronic graft-versus-host disease on the outcome of allogeneic peripheral blood stem cell transplantation for advanced haematological malignancies.
Brunet S, Urbano-Ispizua A, Ojeda E, Ruiz D, Moraleda JM, Díaz MA, Caballero D, Bargay J, de la Rubia J, Solano C, Zuazu J, Diez JL, de la Serna J, Espigado I, Alegre A, Torres JP, Jurado M, Fernández M, Vivancos P, Carreras E, Hernández F, Maldonado J, Sierra J, Rozman C; Spanish Group of Allogenic-PBT, Spain. Brunet S, et al. Among authors: diez jl. Br J Haematol. 2001 Sep;114(3):544-50. doi: 10.1046/j.1365-2141.2001.03002.x. Br J Haematol. 2001. PMID: 11552978 Free article.
The number of donor CD3(+) cells is the most important factor for graft failure after allogeneic transplantation of CD34(+) selected cells from peripheral blood from HLA-identical siblings.
Urbano-Ispizua A, Rozman C, Pimentel P, Solano C, de la Rubia J, Brunet S, Pérez-Oteiza J, Ferrá C, Zuazu J, Caballero D, Carvalhais A, Díez JL, Espigado I, Martínez C, Campilho F, Sanz MA, Sierra J, García-Conde J, Montserrat E; Spanish Group for Allogenic Peripheral Blood Transplantation. Urbano-Ispizua A, et al. Among authors: diez jl. Blood. 2001 Jan 15;97(2):383-7. doi: 10.1182/blood.v97.2.383. Blood. 2001. PMID: 11154212 Free article.
Rabbit antithymocyte globulin versus horse antithymocyte globulin for treatment of acquired aplastic anemia: a retrospective analysis.
Vallejo C, Montesinos P, Polo M, Cuevas B, Morado M, Rosell A, Xicoy B, Díez JL, Salamero O, Cedillo Á, Martínez P, Rayón C; Bone Marrow Failure Spanish Study Group (Pethema-GETH). Vallejo C, et al. Among authors: diez jl. Ann Hematol. 2015 Jun;94(6):947-54. doi: 10.1007/s00277-015-2305-3. Epub 2015 Feb 13. Ann Hematol. 2015. PMID: 25672649
Relapse of chronic myeloid leukemia after allogeneic stem cell transplantation: outcome and prognostic factors: the Chronic Myeloid Leukemia Subcommittee of the GETH (Grupo Español de Trasplante Hemopoyético).
Martínez C, Gomez V, Tomás JF, Parody R, Sureda A, Sanz G, Cañizo C, Díez JL, Boqué C; CML Subcommittee of the Spanish Group of Hematopoietic Transplantation (Grupo Español de Trasplante Hemopoyética, GETH). Martínez C, et al. Among authors: diez jl. Bone Marrow Transplant. 2005 Aug;36(4):301-6. doi: 10.1038/sj.bmt.1705063. Bone Marrow Transplant. 2005. PMID: 15968278
134 results